167 related articles for article (PubMed ID: 7225430)
1. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
Swanson AB; Miller EC; Miller JA
Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
[TBL] [Abstract][Full Text] [Related]
3. The mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants.
Swanson AB; Chambliss DD; Blomquist JC; Miller EC; Miller JA
Mutat Res; 1979 Apr; 60(2):143-53. PubMed ID: 379623
[TBL] [Abstract][Full Text] [Related]
4. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
[TBL] [Abstract][Full Text] [Related]
5. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice.
Randerath K; Haglund RE; Phillips DH; Reddy MV
Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of allylbenzene analogues in vivo and in vitro through the epoxide-diol pathway.
Delaforge M; Janiaud P; Levi P; Morizot JP
Xenobiotica; 1980 Oct; 10(10):737-44. PubMed ID: 7456490
[TBL] [Abstract][Full Text] [Related]
7. Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.
Chan VS; Caldwell J
Food Chem Toxicol; 1992 Oct; 30(10):831-6. PubMed ID: 1427504
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J x C3H/HeJ F1 mice.
Wiseman RW; Miller EC; Miller JA; Liem A
Cancer Res; 1987 May; 47(9):2275-83. PubMed ID: 3567921
[TBL] [Abstract][Full Text] [Related]
9. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice.
Phillips DH; Reddy MV; Randerath K
Carcinogenesis; 1984 Dec; 5(12):1623-8. PubMed ID: 6499113
[TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases.
Luo G; Qato MK; Guenthner TM
Drug Metab Dispos; 1992; 20(3):440-5. PubMed ID: 1521503
[TBL] [Abstract][Full Text] [Related]
11. Interactions of safrole and isosafrole and their metabolites with cytochromes P-450.
Ioannides C; Delaforge M; Parke DV
Chem Biol Interact; 1985 May; 53(3):303-11. PubMed ID: 4006010
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the role of the 2',3'-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs.
Guenthner TM; Luo G
Toxicology; 2001 Mar; 160(1-3):47-58. PubMed ID: 11246123
[TBL] [Abstract][Full Text] [Related]
13. DNA adducts derived from safrole, estragole and related compounds, and from benzene and its metabolites.
Phillips DH
IARC Sci Publ; 1994; (125):131-40. PubMed ID: 7806308
[No Abstract] [Full Text] [Related]
14. The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole.
Miller JA; Miller EC
Br J Cancer; 1983 Jul; 48(1):1-15. PubMed ID: 6191767
[TBL] [Abstract][Full Text] [Related]
15. Detoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.
Luo G; Guenthner TM
Drug Metab Dispos; 1994; 22(5):731-7. PubMed ID: 7835225
[TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal absorption in the rat of anisole, trans-anethole, butylhydroxyanisole and safrole].
Fritsch P; de Saint Blanquat G; Derache R
Food Cosmet Toxicol; 1975 Jun; 13(3):359-63. PubMed ID: 1158324
[No Abstract] [Full Text] [Related]
17. Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1'-hydroxyestragole.
Anthony A; Caldwell J; Hutt AJ; Smith RL
Food Chem Toxicol; 1987 Nov; 25(11):799-806. PubMed ID: 3121480
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
[TBL] [Abstract][Full Text] [Related]
19. Mutagenicity of trans-anethole, estragole, eugenol, and safrole in the Ames Salmonella typhimurium assay.
To LP; Hunt TP; Andersen ME
Bull Environ Contam Toxicol; 1982 Jun; 28(6):647-54. PubMed ID: 7049270
[No Abstract] [Full Text] [Related]
20. The relationship between the metabolism and toxicity of benzodioxole compounds.
Bridges JW; Fennell TR
Adv Exp Med Biol; 1981; 136 Pt B():881-93. PubMed ID: 7344519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
